SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Sylvester who wrote (1655)9/28/1998 2:30:00 PM
From: bert100  Respond to of 4140
 
That analysis is right on. I for one have been a holder since $2.00 and up. I am typically a long term investor in SNRS, but have scaled down my position to try and make some money in other stocks. My last purchase was at 5.93. I have others at 3.5, 3.65, 4, 4.20, and 4.3. I did sell some at 8 5/8 and 7.59 and hope to reenter at the end of this year.

Bert



To: Sylvester who wrote (1655)9/28/1998 3:45:00 PM
From: majormember  Read Replies (1) | Respond to of 4140
 
Sylvester,

Excellent post!

Agree on most of your comments except I think we will perform
in an over 20+ range once FDA approval is in. Higher if Wall
Street begins building "castles in the air" based on per
procedure fee.

Best,
Skane


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News